Postpartum thyroiditis differential diagnosis: Difference between revisions

Jump to navigation Jump to search
No edit summary
 
(33 intermediate revisions by 3 users not shown)
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{Postpartum thyroiditis}}
[[Image:Home_logo1.png|right|250px|link=https://www.wikidoc.org/index.php/Postpartum_thyroiditis]]
{{CMG}} {{AE}} {{MMF}}
{{CMG}} {{AE}} {{MMF}}{{SKA}}


==Overview==
==Overview==
Postpartum thyroiditis must be differentiated from other causes of [[thyroiditis]], such as [[De Quervain's thyroiditis]], [[Hashimoto's thyroiditis]], [[Riedel's thyroiditis]], and suppurative thyroiditis.
[[Postpartum thyroiditis]] must be differentiated from other causes of [[thyroiditis]], such as [[De Quervain's thyroiditis]], [[Hashimoto's thyroiditis]], [[Riedel's thyroiditis]], and suppurative thyroiditis. Postpartum thyroiditis must also be differentiated from other diseases which cause [[hypothyroidism]]. As postpartum thyroiditis may cause transient thyrotoxic symptoms, the diseases causing [[thyrotoxicosis]] must also be considered in the differential diagnosis.
 
==Differentiating Postpartum Thyroiditis from other Diseases==
==Differentiating Postpartum Thyroiditis from other Diseases==
*Postpartum thyroiditis must be differentiated from other causes of [[thyroiditis]], such as [[De Quervain's thyroiditis]], [[Hashimoto's thyroiditis]], [[Riedel's thyroiditis]], and suppurative thyroiditis.<ref name="urlThyroiditis — NEJM">{{cite web |url=http://www.nejm.org/doi/full/10.1056/NEJMra021194 |title=Thyroiditis — NEJM |format= |work= |accessdate=}}</ref>
===Differentiating postpartum thyroiditis from other causes of thyroiditis===
*Postpartum thyroiditis must be differentiated from other causes of [[thyroiditis]], such as [[De Quervain's thyroiditis]], [[Hashimoto's thyroiditis]], [[Riedel's thyroiditis]], and suppurative thyroiditis.<ref name="urlThyroiditis — NEJM">{{cite web |url=http://www.nejm.org/doi/full/10.1056/NEJMra021194 |title=Thyroiditis — NEJM |format= |work= |accessdate=}}</ref><ref name="pmid28781832">{{cite journal| author=Akuzawa N, Yokota T, Suzuki T, Kurabayashi M| title=Acute suppurative thyroiditis caused by Streptococcus agalactiae infection: a case report. | journal=Clin Case Rep | year= 2017 | volume= 5 | issue= 8 | pages= 1238-1242 | pmid=28781832 | doi=10.1002/ccr3.1048 | pmc=5538065 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=28781832  }}</ref><ref name="pmid287818323">{{cite journal| author=Akuzawa N, Yokota T, Suzuki T, Kurabayashi M| title=Acute suppurative thyroiditis caused by Streptococcus agalactiae infection: a case report. | journal=Clin Case Rep | year= 2017 | volume= 5 | issue= 8 | pages= 1238-1242 | pmid=28781832 | doi=10.1002/ccr3.1048 | pmc=5538065 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=28781832  }}</ref>
{| align="center"
{| align="center"
|-
|-
Line 13: Line 15:
! style="background:#4479BA; color: #FFFFFF;" | Conditions
! style="background:#4479BA; color: #FFFFFF;" | Conditions
! style="background:#4479BA; color: #FFFFFF;" |Causes
! style="background:#4479BA; color: #FFFFFF;" |Causes
! style="background:#4479BA; color: #FFFFFF;" |Age at onset
! style="background:#4479BA; color: #FFFFFF;" |Age of onset (years)
! style="background:#4479BA; color: #FFFFFF;" |Pathological findings
! style="background:#4479BA; color: #FFFFFF;" |Pathological findings
! style="background:#4479BA; color: #FFFFFF;" |Diagnostic approach     
! style="background:#4479BA; color: #FFFFFF;" |Diagnostic approach     
Line 20: Line 22:
| align="center" style="background:#DCDCDC;" |[[Hashimoto's thyroiditis]]
| align="center" style="background:#DCDCDC;" |[[Hashimoto's thyroiditis]]
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
*Autoimmune
*[[Autoimmune]]
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
*All ages, peak at 30-50
*All ages, peak at 30-50
Line 26: Line 28:
*Lymphocytic infiltration
*Lymphocytic infiltration
*Germinal centers
*Germinal centers
*Fibrosis (in some variants)
*[[Fibrosis]] (in some variants)
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
*[[Thyroid function tests|Increased TSH]] (hypothyroidism)
*[[Thyroid function tests|Increased TSH]] ([[hypothyroidism]])
*[[Thyroid peroxidase|TPO antibodies]] present in high titer
*[[Thyroid peroxidase|TPO antibodies]] present in high titer
*[[I-123 thyroid imaging|I-123]] uptake usually decreased
*[[I-123 thyroid imaging|I-123]] uptake usually decreased
Line 39: Line 41:
*20-60
*20-60
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
*Giant cells
*[[Giant cells]]
*Granulomas
*[[Granulomas]]
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
*[[Thyroid function tests|Increased TSH]] (hypothyroidism) and/or
*[[Thyroid function tests|Increased TSH]] ([[hypothyroidism]]) and/or
* [[Thyroid function tests|Decreased TSH]] (Thyrotoxicosis)
* [[Thyroid function tests|Decreased TSH]] ([[thyrotoxicosis]])
*[[Thyroid peroxidase|TPO antibodies]] absent or very low titer
*[[Thyroid peroxidase|TPO antibodies]] absent or very low titer
*[[I-123 thyroid imaging|I-123]] uptake decreased
*[[I-123 thyroid imaging|I-123]] uptake decreased
Line 49: Line 51:
| align="center" style="background:#DCDCDC;" |[[Silent thyroiditis]]
| align="center" style="background:#DCDCDC;" |[[Silent thyroiditis]]
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
*Autoimmune
*[[Autoimmune]]
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
*All ages, peak at 30-40
*All ages, peak at 30-40
Line 56: Line 58:
*Lymphoid follicles
*Lymphoid follicles
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
*[[Thyroid function tests|Increased TSH]] (hypothyroidism) and/or
*[[Thyroid function tests|Increased TSH]] ([[hypothyroidism]]) and/or
* [[Thyroid function tests|Decreased TSH]] (transient hypothyroidism)
* [[Thyroid function tests|Decreased TSH]] (transient [[hypothyroidism]])
*[[Thyroid peroxidase|TPO antibodies]] present in high titer
*[[Thyroid peroxidase|TPO antibodies]] present in high titer
*[[I-123 thyroid imaging|I-123]] uptake usually decreased
*[[I-123 thyroid imaging|I-123]] uptake usually decreased
Line 63: Line 65:
| align="center" style="background:#DCDCDC;" |[[Postpartum thyroiditis]]
| align="center" style="background:#DCDCDC;" |[[Postpartum thyroiditis]]
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
*Autoimmune
*[[Autoimmune]]
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
*Childbearing age
*Childbearing age
Line 69: Line 71:
*Lymphocytic infiltration
*Lymphocytic infiltration
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
*[[Thyroid function tests|Increased TSH]] (hypothyroidism) and/or
*[[Thyroid function tests|Increased TSH]] ([[hypothyroidism]]) and/or
* [[Thyroid function tests|Decreased TSH]] (transient hypothyroidism)
* [[Thyroid function tests|Decreased TSH]] (transient [[hypothyroidism]])
*[[Thyroid peroxidase|TPO antibodies]] present in high titer
*[[Thyroid peroxidase|TPO antibodies]] present in high titer
*[[I-123 thyroid imaging|I-123]] uptake usually decreased
*[[I-123 thyroid imaging|I-123]] uptake usually decreased
Line 80: Line 82:
*30-60
*30-60
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
*Dense fibrosis
*Dense [[fibrosis]]
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
*[[Thyroid function tests|Normal TSH]] (euthyroidism)
*[[Thyroid function tests|Normal TSH]] (euthyroidism)
Line 88: Line 90:
| align="center" style="background:#DCDCDC;" |[[Suppurative thyroiditis]]
| align="center" style="background:#DCDCDC;" |[[Suppurative thyroiditis]]
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
*Infection
*[[Infection]]
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
*Children, 20-40
*Children, 20-40
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
*Abscess formation
*[[Abscess]] formation
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
*[[Thyroid function tests|Normal TSH]] (euthyroidism)
*[[Thyroid function tests|Normal TSH]] (euthyroidism)
Line 98: Line 100:
*[[I-123 thyroid imaging|I-123]] uptake normal
*[[I-123 thyroid imaging|I-123]] uptake normal
|}
|}
 
===Differentiating postpartum thyroiditis from other causes of hypothyroidism===
*Postpartum thyroiditis must be differentiated from other causes of [[hypothyroidism]] on the basis of history and symptoms and laboratory findings:<ref name="pmid16734054">{{cite journal |vauthors=Bindra A, Braunstein GD |title=Thyroiditis |journal=Am Fam Physician |volume=73 |issue=10 |pages=1769–76 |year=2006 |pmid=16734054 |doi= |url=}}</ref><ref name="pmid19949140">{{cite journal |vauthors=McDermott MT |title=In the clinic. Hypothyroidism |journal=Ann. Intern. Med. |volume=151 |issue=11 |pages=ITC61 |year=2009 |pmid=19949140 |doi=10.7326/0003-4819-151-11-200912010-01006 |url=}}</ref><ref name="urlThyroiditis — NEJM">{{cite web |url=http://www.nejm.org/doi/full/10.1056/NEJMra021194 |title=Thyroiditis — NEJM |format= |work= |accessdate=}}</ref><ref name="pmid18177256">{{cite journal |vauthors=Aoki Y, Belin RM, Clickner R, Jeffries R, Phillips L, Mahaffey KR |title=Serum TSH and total T4 in the United States population and their association with participant characteristics: National Health and Nutrition Examination Survey (NHANES 1999-2002) |journal=Thyroid |volume=17 |issue=12 |pages=1211–23 |year=2007 |pmid=18177256 |doi=10.1089/thy.2006.0235 |url=}}</ref><ref name="pmid18415684">{{cite journal |vauthors=Lania A, Persani L, Beck-Peccoz P |title=Central hypothyroidism |journal=Pituitary |volume=11 |issue=2 |pages=181–6 |year=2008 |pmid=18415684 |doi=10.1007/s11102-008-0122-6 |url=}}</ref><ref name="pmid25905413">{{cite journal |vauthors=De Groot LJ, Chrousos G, Dungan K, Feingold KR, Grossman A, Hershman JM, Koch C, Korbonits M, McLachlan R, New M, Purnell J, Rebar R, Singer F, Vinik A, Stockigt J |title=Clinical Strategies in the Testing of Thyroid Function |journal= |volume= |issue= |pages= |year= |pmid=25905413 |doi= |url=}}</ref>
*Postpartum thyroiditis must be differentiated from other causes of [[hypothyroidism]] on the basis of history and symptoms and laboratory findings:<ref name="pmid16734054">{{cite journal |vauthors=Bindra A, Braunstein GD |title=Thyroiditis |journal=Am Fam Physician |volume=73 |issue=10 |pages=1769–76 |year=2006 |pmid=16734054 |doi= |url=}}</ref><ref name="pmid19949140">{{cite journal |vauthors=McDermott MT |title=In the clinic. Hypothyroidism |journal=Ann. Intern. Med. |volume=151 |issue=11 |pages=ITC61 |year=2009 |pmid=19949140 |doi=10.7326/0003-4819-151-11-200912010-01006 |url=}}</ref><ref name="urlThyroiditis — NEJM">{{cite web |url=http://www.nejm.org/doi/full/10.1056/NEJMra021194 |title=Thyroiditis — NEJM |format= |work= |accessdate=}}</ref><ref name="pmid18177256">{{cite journal |vauthors=Aoki Y, Belin RM, Clickner R, Jeffries R, Phillips L, Mahaffey KR |title=Serum TSH and total T4 in the United States population and their association with participant characteristics: National Health and Nutrition Examination Survey (NHANES 1999-2002) |journal=Thyroid |volume=17 |issue=12 |pages=1211–23 |year=2007 |pmid=18177256 |doi=10.1089/thy.2006.0235 |url=}}</ref><ref name="pmid18415684">{{cite journal |vauthors=Lania A, Persani L, Beck-Peccoz P |title=Central hypothyroidism |journal=Pituitary |volume=11 |issue=2 |pages=181–6 |year=2008 |pmid=18415684 |doi=10.1007/s11102-008-0122-6 |url=}}</ref><ref name="pmid25905413">{{cite journal |vauthors=De Groot LJ, Chrousos G, Dungan K, Feingold KR, Grossman A, Hershman JM, Koch C, Korbonits M, McLachlan R, New M, Purnell J, Rebar R, Singer F, Vinik A, Stockigt J |title=Clinical Strategies in the Testing of Thyroid Function |journal= |volume= |issue= |pages= |year= |pmid=25905413 |doi= |url=}}</ref>


Line 118: Line 120:
|-
|-
| rowspan="3" style="background:#DCDCDC;" |[[Primary hypothyroidism]]
| rowspan="3" style="background:#DCDCDC;" |[[Primary hypothyroidism]]
| align="center" style="background:#DCDCDC;" |[[Hashimoto's thyroiditis|Autoimmune]] ([[Hashimoto's thyroiditis]])
| align="center" style="background:#DCDCDC;" |[[Hashimoto's thyroiditis|Autoimmune]]  
([[Hashimoto's thyroiditis]])
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | -
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | -
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | -
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | -
Line 144: Line 147:
*[[Riedel's thyroiditis]] usually presents with hard and fixed thyroid mass.
*[[Riedel's thyroiditis]] usually presents with hard and fixed thyroid mass.
|-
|-
| align="center" style="background:#DCDCDC;" |[[Infectious thyroiditis]]
| align="center" style="background:#DCDCDC;" |Infectious thyroiditis
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | +
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | +
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | +
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | +
Line 217: Line 220:
| align="center" style="background:#DCDCDC;" |Trauma induced
| align="center" style="background:#DCDCDC;" |Trauma induced
|-
|-
| align="center" style="background:#DCDCDC;" |Radioiodine induced
| align="center" style="background:#DCDCDC;" |[[Radioiodine]] induced
|-
|-
| align="center" style="background:#DCDCDC;" |Thyroidectomy
| align="center" style="background:#DCDCDC;" |[[Thyroidectomy]]
|-
|-
| align="center" style="background:#DCDCDC;" |Subclinical hypothyroidism
| align="center" style="background:#DCDCDC;" |Subclinical hypothyroidism
Line 235: Line 238:
|-
|-
|}
|}
<br style="clear:left" />''(†)T3RU; Triiodothyronine Resin uptake. (^)TPOAb; [[Thyroid peroxidase]] antibodies. (*)[[TSH]] may be decreased transiently in the [[thyrotoxicosis]]. (**)TPOAb may be present in drug-induced [[Hypothyroidism|hypo]]/[[hyperthyroidism]] such as [[Interferon-alpha]], [[Interleukin 2|interleukin-2]], and [[lithium]].''
<br style="clear:left" />''(†)T3RU; Triiodothyronine Resin uptake. (^)TPOAb; [[Thyroid peroxidase]] antibodies. (*)[[TSH]] may be decreased transiently in the [[thyrotoxicosis]]. (**)TPOAb may be present in drug-induced [[Hypothyroidism|hypothyroidism]] or [[hyperthyroidism]] such as [[Interferon-alpha]], [[Interleukin 2|interleukin-2]], and [[lithium]].''


===Differentiating postpartum thyroiditis from other causes of thyrotoxicosis===
===Differentiating postpartum thyroiditis from other causes of thyrotoxicosis===
*Postpartum thyroiditis can initially present with thyrotoxicosis which must be differentiated from other causes of thyrotoxicosis.<ref name="pmid16734054">{{cite journal |vauthors=Bindra A, Braunstein GD |title=Thyroiditis |journal=Am Fam Physician |volume=73 |issue=10 |pages=1769–76 |year=2006 |pmid=16734054 |doi= |url=}}</ref><ref name="pmid19949140">{{cite journal |vauthors=McDermott MT |title=In the clinic. Hypothyroidism |journal=Ann. Intern. Med. |volume=151 |issue=11 |pages=ITC61 |year=2009 |pmid=19949140 |doi=10.7326/0003-4819-151-11-200912010-01006 |url=}}</ref><ref name="urlThyroiditis — NEJM">{{cite web |url=http://www.nejm.org/doi/full/10.1056/NEJMra021194 |title=Thyroiditis — NEJM |format= |work= |accessdate=}}</ref><ref name="pmid18177256">{{cite journal |vauthors=Aoki Y, Belin RM, Clickner R, Jeffries R, Phillips L, Mahaffey KR |title=Serum TSH and total T4 in the United States population and their association with participant characteristics: National Health and Nutrition Examination Survey (NHANES 1999-2002) |journal=Thyroid |volume=17 |issue=12 |pages=1211–23 |year=2007 |pmid=18177256 |doi=10.1089/thy.2006.0235 |url=}}</ref><ref name="pmid18415684">{{cite journal |vauthors=Lania A, Persani L, Beck-Peccoz P |title=Central hypothyroidism |journal=Pituitary |volume=11 |issue=2 |pages=181–6 |year=2008 |pmid=18415684 |doi=10.1007/s11102-008-0122-6 |url=}}</ref><ref name="pmid25905413">{{cite journal |vauthors=De Groot LJ, Chrousos G, Dungan K, Feingold KR, Grossman A, Hershman JM, Koch C, Korbonits M, McLachlan R, New M, Purnell J, Rebar R, Singer F, Vinik A, Stockigt J |title=Clinical Strategies in the Testing of Thyroid Function |journal= |volume= |issue= |pages= |year= |pmid=25905413 |doi= |url=}}</ref><ref name="urlClinical Finding and Thyroid Function in Women with Struma Ovarii">{{cite web |url=https://www.hindawi.com/archive/2013/717584/ |title=Clinical Finding and Thyroid Function in Women with Struma Ovarii |format= |work= |accessdate=}}</ref><ref name="pmid25146390">{{cite journal |vauthors=Vaidya B, Pearce SH |title=Diagnosis and management of thyrotoxicosis |journal=BMJ |volume=349 |issue= |pages=g5128 |year=2014 |pmid=25146390 |doi= |url=}}</ref><ref name="urlThink thyrotoxicosis factitia - measure thyroglobulin | The BMJ">{{cite web |url=http://www.bmj.com/content/349/bmj.g5128/rr/763450 |title=Think thyrotoxicosis factitia - measure thyroglobulin &#124; The BMJ |format= |work= |accessdate=}}</ref>
*Postpartum thyroiditis can initially present with [[thyrotoxicosis]] which must be differentiated from other causes of [[thyrotoxicosis]].<ref name="pmid16734054">{{cite journal |vauthors=Bindra A, Braunstein GD |title=Thyroiditis |journal=Am Fam Physician |volume=73 |issue=10 |pages=1769–76 |year=2006 |pmid=16734054 |doi= |url=}}</ref><ref name="pmid19949140">{{cite journal |vauthors=McDermott MT |title=In the clinic. Hypothyroidism |journal=Ann. Intern. Med. |volume=151 |issue=11 |pages=ITC61 |year=2009 |pmid=19949140 |doi=10.7326/0003-4819-151-11-200912010-01006 |url=}}</ref><ref name="urlThyroiditis — NEJM">{{cite web |url=http://www.nejm.org/doi/full/10.1056/NEJMra021194 |title=Thyroiditis — NEJM |format= |work= |accessdate=}}</ref><ref name="pmid18177256">{{cite journal |vauthors=Aoki Y, Belin RM, Clickner R, Jeffries R, Phillips L, Mahaffey KR |title=Serum TSH and total T4 in the United States population and their association with participant characteristics: National Health and Nutrition Examination Survey (NHANES 1999-2002) |journal=Thyroid |volume=17 |issue=12 |pages=1211–23 |year=2007 |pmid=18177256 |doi=10.1089/thy.2006.0235 |url=}}</ref><ref name="pmid18415684">{{cite journal |vauthors=Lania A, Persani L, Beck-Peccoz P |title=Central hypothyroidism |journal=Pituitary |volume=11 |issue=2 |pages=181–6 |year=2008 |pmid=18415684 |doi=10.1007/s11102-008-0122-6 |url=}}</ref><ref name="pmid25905413">{{cite journal |vauthors=De Groot LJ, Chrousos G, Dungan K, Feingold KR, Grossman A, Hershman JM, Koch C, Korbonits M, McLachlan R, New M, Purnell J, Rebar R, Singer F, Vinik A, Stockigt J |title=Clinical Strategies in the Testing of Thyroid Function |journal= |volume= |issue= |pages= |year= |pmid=25905413 |doi= |url=}}</ref><ref name="urlClinical Finding and Thyroid Function in Women with Struma Ovarii">{{cite web |url=https://www.hindawi.com/archive/2013/717584/ |title=Clinical Finding and Thyroid Function in Women with Struma Ovarii |format= |work= |accessdate=}}</ref><ref name="pmid25146390">{{cite journal |vauthors=Vaidya B, Pearce SH |title=Diagnosis and management of thyrotoxicosis |journal=BMJ |volume=349 |issue= |pages=g5128 |year=2014 |pmid=25146390 |doi= |url=}}</ref><ref name="urlThink thyrotoxicosis factitia - measure thyroglobulin | The BMJ">{{cite web |url=http://www.bmj.com/content/349/bmj.g5128/rr/763450 |title=Think thyrotoxicosis factitia - measure thyroglobulin &#124; The BMJ |format= |work= |accessdate=}}</ref>
{| class="wikitable" align="center" style="border: 0px; margin: 3px;"
{| class="wikitable" align="center" style="border: 0px; margin: 3px;"
! colspan="2" rowspan="2" align="center" style="background: #4479BA; color: #FFFFFF; " |Disease
! colspan="2" rowspan="2" align="center" style="background: #4479BA; color: #FFFFFF; " |Disease
Line 248: Line 251:
! align="center" style="background: #4479BA; color: #FFFFFF; " |<small> Pain  
! align="center" style="background: #4479BA; color: #FFFFFF; " |<small> Pain  
! align="center" style="background: #4479BA; color: #FFFFFF; " |<small> TSH  
! align="center" style="background: #4479BA; color: #FFFFFF; " |<small> TSH  
! align="center" style="background: #4479BA; color: #FFFFFF; " |<small> Free T4  
! align="center" style="background: #4479BA; color: #FFFFFF; " |<small>Free T4  
! align="center" style="background: #4479BA; color: #FFFFFF; " |<small> T3  
! align="center" style="background: #4479BA; color: #FFFFFF; " |<small> T3  
! align="center" style="background: #4479BA; color: #FFFFFF; " |<small> T3RU<small>†
! align="center" style="background: #4479BA; color: #FFFFFF; " |<small> T3RU<small>†
! align="center" style="background: #4479BA; color: #FFFFFF; " |<small> Thyroglobin  
! align="center" style="background: #4479BA; color: #FFFFFF; " |<small>Thyroglobin  
! align="center" style="background: #4479BA; color: #FFFFFF; " |<small> TRH  
! align="center" style="background: #4479BA; color: #FFFFFF; " |<small> TRH  
! align="center" style="background: #4479BA; color: #FFFFFF; " |<small> TSH Receptor Antibody
! align="center" style="background: #4479BA; color: #FFFFFF; " |<small> TSH Receptor Antibody
Line 326: Line 329:
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |Absent
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |Absent
| align="left" style="padding: 5px 5px; background: #F5F5F5;" |
| align="left" style="padding: 5px 5px; background: #F5F5F5;" |
* Patient may have opthalmopathy and dermopathy
* Opthalmopathy and [[dermopathy]] may be present
|-
|-
| align="center" style="background:#DCDCDC;" |[[Toxic thyroid nodule]]
| align="center" style="background:#DCDCDC;" |[[Toxic thyroid nodule]]
Line 355: Line 358:
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |Absent
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |Absent
| align="left" style="padding: 5px 5px; background: #F5F5F5;" |
| align="left" style="padding: 5px 5px; background: #F5F5F5;" |
*Inappropriately normal or increased TSH
*Inappropriately normal or increased [[TSH]]
|-
|-
| rowspan="1" style="background:#DCDCDC;" |[[Tertiary hyperthyroidism]]  
| rowspan="1" style="background:#DCDCDC;" |[[Tertiary hyperthyroidism]]  
| align="center" style="background:#DCDCDC;" |[[Hyperthyroidism|Tertiary hyperthyroidism]]
| align="center" style="background:#DCDCDC;" |[[Hyperthyroidism|Tertiary hyperthyroidism]]
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |-
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | -
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |-
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | -
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |↑
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |↑
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |↑
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |↑
Line 370: Line 373:
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |Absent
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |Absent
| align="left" style="padding: 5px 5px; background: #F5F5F5;" |
| align="left" style="padding: 5px 5px; background: #F5F5F5;" |
*Inappropriately normal or increased TSH
*Inappropriately normal or increased [[TSH]]
|-
|-
| rowspan="2" style="background:#DCDCDC;" |Drug induced
| rowspan="2" style="background:#DCDCDC;" |Drug induced
Line 385: Line 388:
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |Absent
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |Absent
| align="left" style="padding: 5px 5px; background: #F5F5F5;" |
| align="left" style="padding: 5px 5px; background: #F5F5F5;" |
*High urinary iodine
*High urinary [[iodine]]
|-
|-
| align="center" style="background:#DCDCDC;" |[[Amiodarone|Amiodarone type 2]]
| align="center" style="background:#DCDCDC;" |[[Amiodarone|Amiodarone type 2]]
Line 399: Line 402:
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |Absent
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |Absent
| align="left" style="padding: 5px 5px; background: #F5F5F5;" |
| align="left" style="padding: 5px 5px; background: #F5F5F5;" |
*High urinary iodine
*High urinary [[iodine]]
|-
|-
| rowspan="3" style="background:#DCDCDC;" |Others
| rowspan="3" style="background:#DCDCDC;" |Others
Line 414: Line 417:
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |Absent
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |Absent
| align="left" style="padding: 5px 5px; background: #F5F5F5;" |
| align="left" style="padding: 5px 5px; background: #F5F5F5;" |
*Decreased thyroglobulin
*Decreased [[thyroglobulin]]
|-
|-
| align="center" style="background:#DCDCDC;" |[[Trophoblastic disease]]
| align="center" style="background:#DCDCDC;" |[[Trophoblastic disease]]
Line 423: Line 426:
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |Normal/↑
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |Normal/↑
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |↑
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |↑
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |-
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | -
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |Normal
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |Normal
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |Absent
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |Absent
Line 437: Line 440:
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |Normal/↑
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |Normal/↑
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |↓
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |↓
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |-
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | -
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |Normal
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |Normal
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |Absent
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |Absent
Line 446: Line 449:
|}
|}
<small>''(†)T3RU; Triiodothyronine Resin uptake. (^)TPOAb; [[Thyroid peroxidase]] antibodies.''</small>
<small>''(†)T3RU; Triiodothyronine Resin uptake. (^)TPOAb; [[Thyroid peroxidase]] antibodies.''</small>
===Differentiating various diseases on the basis of type of thyroid dysfunction===
{| class="wikitable"
! rowspan="2" |Stages
! rowspan="2" |Peek
presenting
purpural
month
! rowspan="2" |Disease
! colspan="4" |Symptoms and Signs
! colspan="7" |Labs
! rowspan="2" |Mechanisum
|-
!Fatiuge
!Neck
swelling
!Low
mood
!Irritability
!TSH
!FT4
!TPO ab
!ESR
!RAI
U
!Thyroid U/S
!Microscopic
Picture
|-
!Persistent
hyperthyroidism
|4-6
|[[Grave's disease]]
| +
|Small
painful
mass
| +
| +
Early
|↓
|↑↑
|Neg
|↑
|↑
|Diffusely
enlarged
hypervascular
heterogeneous
echotexture
|hyperplastic
follicles due to
eosinophilic
cytoplasm
scalloping
|TSHR
activating
antibodies
|-
! rowspan="5" |Transient
hyperthyroidism
| rowspan="5" |2-4
|[[Silent thyroiditis]]
| +
|Small
painless
goiter
| +
Late
| +
Early
|NL
or ↓
|↑↑
|50%
|NL
|↓
|Markedly
decreased
vascularity
variable
heterogeneous
texture
|Lymphocytic
infiltration & follicles
|CD4
T-cell
activation
mutation
|-
|[[Postpartum thyroiditis]]
| +
|Small
painless goiter
| +
Late
| +
Early
|NL
or ↓
|↑↑
|>80% 
|↑
|↓
|Hypoechoic
diffusely
enlarged
with
normal
or decreased
vascularity
|Lymphocytic
infiltration & follicles
|Reg
T-cell
gain in
function
mutation
|-
|[[De Quervain's thyroiditis|Subacute (de Quervain's)]]
[[De Quervain's thyroiditis|granulomatous thyroiditis]]
| +
|Small
painful
mass
| +
late
| +
early
|nl
or ↓
|↑↑
|neg
|↑
|↓
|Diffusely
enlarged &
normal or
decreased
 vascularity
|Giant cells
granulomas
|Systemic
viral
infections
|-
|[[Factitious thyrotoxicosis|Factitious]]
[[Factitious thyrotoxicosis|thyrotoxicosis]]
| +
|Nl
|Neg
| +
Early
|NL
or ↓
|↑↑
|Neg
|NL
|↓
|NL
|Normal
histology
|Thyroixine
intake
|-
|Acute suppurative
thyroiditis
| +
|Small
painful
mass
| +
Late
| +
Early
|NL
or ↓
|↑↑
|Neg
|↑
|↓
|Variable
heterogeneous
texture
perithyroidal
hypoechoic
space due to
abscess
|Polymorphonuclear
leukocytes
lymphocytes
exudates
|Viral, Bacterial
|-
! rowspan="3" |Destructive
hyperthyroidism
| rowspan="3" |4-6
|[[De Quervain's thyroiditis|Subacute (de Quervain's)]]
[[De Quervain's thyroiditis|granulomatous thyroiditis]]
| +
|Small
painful
mass
| +
Late
| +
Early
|NL
or ↓
|↑↑
|Neg
|↑
|↓
|Diffusely
enlarged
& normal or
decreased
 vascularity
|Gaint cells
granulomas
|Systemic
viral
infections
|-
|[[Postpartum thyroiditis|Postpartum]]
[[Postpartum thyroiditis|thyroiditis]]
| +
|Small
painless
goiter
| +
Late
| +
Early
|NL
or ↓
|↑↑
|>80% 
|↑
|↓
|Hypoechoic
diffusely
enlarged&
normal or
decreased
vascularity
|Lymphocytic
infiltration &
follicles
|Reg
T-cell
gain in
function
mutation
|-
|Acute suppurative
thyroiditis
| +
|Small
painful
mass
| +
Late
| +
Early
|NL
or ↓
|↑↑
|neg
|↑
|↓
|Variable
heterogeneous
texture
perithyroidal
hypoechoic
space due to
abscess
|Polymorphonuclear leukocytes
lymphocytes
exudates
|Viral,
Bacterial
|-
! rowspan="4" |'''Transient'''
'''hypothyroidism'''
| rowspan="4" |2-4
|[[Postpartum thyroiditis|Postpartum]]
[[Postpartum thyroiditis|thyroiditis]]
| +
|Small
painless
goiter
| +
Late
| +
Early
|NL
or ↑
|↓
|>80% 
|↑
|↓
| Hypoechoic
diffusely
enlarged
& normal or
decreased
vasclarity
|Lymphocytic
infiltration &
follicles
|Reg
T-cell
gain in
function
mutation
|-
|[[Silent thyroiditis|Silent]]
[[Silent thyroiditis|thyroiditis]]
| +
|Small
painless
goiter
| +
Late
| +
Early
|NL
or ↑
|↓
| +
|NL
|↓
|Markedly
decreased
vascularity
variable
heterogeneous
texture
|Lymphocytic infiltration
& follicles
|CD4
T-cell
activation
mutation
|-
|[[De Quervain's thyroiditis|Subacute (de Quervain's)]]
[[De Quervain's thyroiditis|granulomatous thyroiditis]]
| +
|Small
painful
mass
| +
Late
| +
Early
|NL
or ↑
|↓
|Neg
|↑
|↓
|Diffusely
enlarged
normal or
decreased
 vasclarity
|Giant cells &
granulomas
|Systemic
viral
infections
|-
|Acute suppurative
thyroiditis
| +
|Small
painful
mass
| +
Late
| +
Early
|NL
or ↑
|↓
|Neg
|↑
|↓
|Variable
heterogeneous
texture
perithyroidal
hypoechoic
space due to
abcess
|Polymorphonuclear leukocytes
lymphocytes
exudates
|Infections
viral,bacterial
|-
! rowspan="4" |'''Persistent'''
'''hypothyroidism'''
| rowspan="4" |6
|[[Riedel's thyroiditis|Riedel's]]
[[Riedel's thyroiditis|thyroiditis]]
| +
|Small
painful
mass
| +
Late
| +
Early
|↑
|↓
|75%
|↑
|↓
|Homogeneously
hypoechoic
fibrotic
invasion of the
adjacent
structures
|Lymphocytes, plasma cells, and eosinophils in a dense matrix of hyalinized connective tissue
|Viral
Bacterial
|-
|[[Postpartum thyroiditis|Postpartum]]
[[Postpartum thyroiditis|thyroiditis]]
| +
|Small
painless
goiter
| +
Late
| +
Early
|↑
|↓
|>80% 
|↑
|↓
|Hypoechoic
diffusely
enlarged&
normal
or decreased
vasclarity
|Variable
heterogeneous
texture,
hypoechogenic
|Reg
T-cell
gain in
function
mutation
|-
|[[Hashimoto's thyroiditis|Hashimoto's]]
[[Hashimoto's thyroiditis|thyroiditis]]
| +
|Painful
mass
| +
Late
| +
Early
|↑
|↓
|95%
|↑
|↓
|Heterogeneous
echotexture
decreased
vasclarity
hypoechoic
micronodules
|Lymphoid
follicles
germinal centers
Hurthle cells
|Reg T-cell
dysfunction
|-
|Acute suppurative
thyroiditis
| +
|Small
painful
mass
| +
Late
| +
Early
|↑
|↓
|Neg
|↑
|↓
|Variable
heterogeneous
texture
perithyroidal
hypoechoic
space due to
abcess
|Polymorphonuclear leukocytes
lymphocytes
exudates
|Systemic
viral
infections
|}


==References==
==References==

Latest revision as of 19:21, 25 February 2019

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Furqan M M. M.B.B.S[2]Sunny Kumar MD [3]

Overview

Postpartum thyroiditis must be differentiated from other causes of thyroiditis, such as De Quervain's thyroiditis, Hashimoto's thyroiditis, Riedel's thyroiditis, and suppurative thyroiditis. Postpartum thyroiditis must also be differentiated from other diseases which cause hypothyroidism. As postpartum thyroiditis may cause transient thyrotoxic symptoms, the diseases causing thyrotoxicosis must also be considered in the differential diagnosis.

Differentiating Postpartum Thyroiditis from other Diseases

Differentiating postpartum thyroiditis from other causes of thyroiditis

Conditions Causes Age of onset (years) Pathological findings Diagnostic approach
Hashimoto's thyroiditis
  • All ages, peak at 30-50
  • Lymphocytic infiltration
  • Germinal centers
  • Fibrosis (in some variants)
Painful subacute (De Quervain's) thyroiditis
  • Unknown
  • 20-60
Silent thyroiditis
  • All ages, peak at 30-40
  • Lymphocytic infiltration
  • Lymphoid follicles
Postpartum thyroiditis
  • Childbearing age
  • Lymphocytic infiltration
Riedel's thyroiditis
  • Unknown
  • 30-60
Suppurative thyroiditis
  • Children, 20-40

Differentiating postpartum thyroiditis from other causes of hypothyroidism

  • Postpartum thyroiditis must be differentiated from other causes of hypothyroidism on the basis of history and symptoms and laboratory findings:[4][5][1][6][7][8]
Disease History and symptoms Laboratory findings Additional findings
Fever Pain TSH Free T4 T3 T3RU Thyroglobin TRH TPOAb^
Primary hypothyroidism Autoimmune

(Hashimoto's thyroiditis)

- - * Normal/ Normal/↓ Normal/ Normal Present (high titer)
Riedel's thyroiditis - - Normal/↑ Normal/↓ Normal/↓ Normal/↓ Normal Normal Usually present
Infectious thyroiditis + + Normal Normal Normal Normal Normal Normal Absent
Transient hypothyroidism Subacute (de Quervain's) thyroiditis +/- +/- ↑/ ↓/ Normal Normal Low/absent
Postpartum thyroiditis +/- +/- ↑/ ↓/ Normal Normal/↑ Present (high titer)
Silent thyroiditis - - ↑/ ↓/ Normal Normal Present (high titer)
Others Drug-induced - - /↓ /↑ Normal Normal/ Normal Absent**
  • History of hyperthyroidism
  • History of trauma
  • History of drug use, surgery, or radiation
Radiation-induced
Trauma induced
Radioiodine induced
Thyroidectomy
Subclinical hypothyroidism - - Normal Normal Normal Normal Normal Normal/
  • Asymptomatic


(†)T3RU; Triiodothyronine Resin uptake. (^)TPOAb; Thyroid peroxidase antibodies. (*)TSH may be decreased transiently in the thyrotoxicosis. (**)TPOAb may be present in drug-induced hypothyroidism or hyperthyroidism such as Interferon-alpha, interleukin-2, and lithium.

Differentiating postpartum thyroiditis from other causes of thyrotoxicosis

Disease History and symptoms Laboratory findings Additional findings
Fever Pain TSH Free T4 T3 T3RU Thyroglobin TRH TSH Receptor Antibody TPOAb^
Thyroiditis Postpartum thyroiditis +/- +/- ↑/ ↓/ Normal Normal/↑ Absent Present (high titer)
Hashimoto's thyroiditis (Hashitoxicosis) - - * Normal/ Normal/↓ Normal/ Normal Absent Present (high titer)
Subacute (de Quervain's) thyroiditis +/- +/- ↑/ ↓/ Normal Normal Absent Low/absent
Silent thyroiditis - - ↑/ ↓/ Normal Normal Absent Present (high titer)
Primary hyperthyroidism Grave's disease - - Normal/ Normal Present Absent
Toxic thyroid nodule - - Normal/↑ ↑(hot nodule) Normal/ Normal Absent Absent

-

Secondary hyperthyroidism Pituitary adenoma - - Normal/↑ Normal/ Normal Absent Absent
  • Inappropriately normal or increased TSH
Tertiary hyperthyroidism Tertiary hyperthyroidism - - Normal/ Absent Absent
  • Inappropriately normal or increased TSH
Drug induced Amiodarone type 1 - - Normal/↑ Normal/ Normal Absent Absent
Amiodarone type 2 - - Normal/↑ Absent/↓ Normal/ Normal Absent Absent
Others Factitious thyrotoxicosis - - Normal/↑ Normal Absent Absent
Trophoblastic disease - - Normal/↑ - Normal Absent Absent

-

Struma ovarii - - Normal/↑ - Normal Absent Absent

-

(†)T3RU; Triiodothyronine Resin uptake. (^)TPOAb; Thyroid peroxidase antibodies.

Differentiating various diseases on the basis of type of thyroid dysfunction

Stages Peek

presenting purpural month

Disease Symptoms and Signs Labs Mechanisum
Fatiuge Neck

swelling

Low

mood

Irritability TSH FT4 TPO ab ESR RAI

U

Thyroid U/S Microscopic

Picture

Persistent

hyperthyroidism

4-6 Grave's disease + Small

painful

mass

+ +

Early

↑↑ Neg Diffusely

enlarged

hypervascular

heterogeneous

echotexture

hyperplastic

follicles due to

eosinophilic

cytoplasm

scalloping

TSHR

activating

antibodies

Transient

hyperthyroidism

2-4 Silent thyroiditis + Small

painless

goiter

+

Late

+

Early

NL

or ↓

↑↑ 50% NL Markedly

decreased

vascularity

variable

heterogeneous

texture

Lymphocytic

infiltration & follicles

CD4

T-cell

activation

mutation

Postpartum thyroiditis + Small

painless goiter

+

Late

+

Early

NL

or ↓

↑↑ >80%  Hypoechoic

diffusely

enlarged

with

normal

or decreased

vascularity

Lymphocytic

infiltration & follicles

Reg

T-cell

gain in

function

mutation

Subacute (de Quervain's)

granulomatous thyroiditis

+ Small

painful

mass

+

late

+

early

nl

or ↓

↑↑ neg Diffusely

enlarged &

normal or

decreased

 vascularity

Giant cells

granulomas

Systemic

viral

infections

Factitious

thyrotoxicosis

+ Nl Neg +

Early

NL

or ↓

↑↑ Neg NL NL Normal

histology

Thyroixine

intake

Acute suppurative

thyroiditis

+ Small

painful

mass

+

Late

+

Early

NL

or ↓

↑↑ Neg Variable

heterogeneous

texture

perithyroidal

hypoechoic

space due to

abscess

Polymorphonuclear

leukocytes

lymphocytes

exudates

Viral, Bacterial
Destructive

hyperthyroidism

4-6 Subacute (de Quervain's)

granulomatous thyroiditis

+ Small

painful

mass

+

Late

+

Early

NL

or ↓

↑↑ Neg Diffusely

enlarged

& normal or

decreased

 vascularity

Gaint cells

granulomas

Systemic

viral

infections

Postpartum

thyroiditis

+ Small

painless

goiter

+

Late

+

Early

NL

or ↓

↑↑ >80%  Hypoechoic

diffusely

enlarged&

normal or

decreased

vascularity

Lymphocytic

infiltration & follicles

Reg

T-cell

gain in

function

mutation

Acute suppurative

thyroiditis

+ Small

painful

mass

+

Late

+

Early

NL

or ↓

↑↑ neg Variable

heterogeneous

texture

perithyroidal

hypoechoic

space due to

abscess

Polymorphonuclear leukocytes

lymphocytes

exudates

Viral,

Bacterial

Transient

hypothyroidism

2-4 Postpartum

thyroiditis

+ Small

painless

goiter

+

Late

+

Early

NL

or ↑

>80%   Hypoechoic

diffusely

enlarged

& normal or

decreased

vasclarity

Lymphocytic

infiltration & follicles

Reg

T-cell

gain in

function

mutation

Silent

thyroiditis

+ Small

painless

goiter

+

Late

+

Early

NL

or ↑

+ NL Markedly

decreased

vascularity

variable

heterogeneous

texture

Lymphocytic infiltration

& follicles

CD4

T-cell

activation

mutation

Subacute (de Quervain's)

granulomatous thyroiditis

+ Small

painful

mass

+

Late

+

Early

NL

or ↑

Neg Diffusely

enlarged

normal or

decreased

 vasclarity

Giant cells &

granulomas

Systemic

viral

infections

Acute suppurative

thyroiditis

+ Small

painful

mass

+

Late

+

Early

NL

or ↑

Neg Variable

heterogeneous

texture

perithyroidal

hypoechoic

space due to

abcess

Polymorphonuclear leukocytes

lymphocytes

exudates

Infections

viral,bacterial

Persistent

hypothyroidism

6 Riedel's

thyroiditis

+ Small

painful

mass

+

Late

+

Early

75% Homogeneously

hypoechoic

fibrotic

invasion of the

adjacent

structures

Lymphocytes, plasma cells, and eosinophils in a dense matrix of hyalinized connective tissue Viral

Bacterial

Postpartum

thyroiditis

+ Small

painless

goiter

+

Late

+

Early

>80%  Hypoechoic

diffusely

enlarged&

normal

or decreased

vasclarity

Variable

heterogeneous

texture,

hypoechogenic

Reg

T-cell

gain in

function

mutation

Hashimoto's

thyroiditis

+ Painful

mass

+

Late

+

Early

95% Heterogeneous

echotexture

decreased

vasclarity

hypoechoic

micronodules

Lymphoid

follicles

germinal centers

Hurthle cells

Reg T-cell

dysfunction

Acute suppurative

thyroiditis

+ Small

painful

mass

+

Late

+

Early

Neg Variable

heterogeneous

texture

perithyroidal

hypoechoic

space due to

abcess

Polymorphonuclear leukocytes

lymphocytes

exudates

Systemic

viral

infections

References

  1. 1.0 1.1 1.2 "Thyroiditis — NEJM".
  2. Akuzawa N, Yokota T, Suzuki T, Kurabayashi M (2017). "Acute suppurative thyroiditis caused by Streptococcus agalactiae infection: a case report". Clin Case Rep. 5 (8): 1238–1242. doi:10.1002/ccr3.1048. PMC 5538065. PMID 28781832.
  3. Akuzawa N, Yokota T, Suzuki T, Kurabayashi M (2017). "Acute suppurative thyroiditis caused by Streptococcus agalactiae infection: a case report". Clin Case Rep. 5 (8): 1238–1242. doi:10.1002/ccr3.1048. PMC 5538065. PMID 28781832.
  4. 4.0 4.1 Bindra A, Braunstein GD (2006). "Thyroiditis". Am Fam Physician. 73 (10): 1769–76. PMID 16734054.
  5. 5.0 5.1 McDermott MT (2009). "In the clinic. Hypothyroidism". Ann. Intern. Med. 151 (11): ITC61. doi:10.7326/0003-4819-151-11-200912010-01006. PMID 19949140.
  6. 6.0 6.1 Aoki Y, Belin RM, Clickner R, Jeffries R, Phillips L, Mahaffey KR (2007). "Serum TSH and total T4 in the United States population and their association with participant characteristics: National Health and Nutrition Examination Survey (NHANES 1999-2002)". Thyroid. 17 (12): 1211–23. doi:10.1089/thy.2006.0235. PMID 18177256.
  7. 7.0 7.1 Lania A, Persani L, Beck-Peccoz P (2008). "Central hypothyroidism". Pituitary. 11 (2): 181–6. doi:10.1007/s11102-008-0122-6. PMID 18415684.
  8. 8.0 8.1 De Groot LJ, Chrousos G, Dungan K, Feingold KR, Grossman A, Hershman JM, Koch C, Korbonits M, McLachlan R, New M, Purnell J, Rebar R, Singer F, Vinik A, Stockigt J. "Clinical Strategies in the Testing of Thyroid Function". PMID 25905413.
  9. "Clinical Finding and Thyroid Function in Women with Struma Ovarii".
  10. Vaidya B, Pearce SH (2014). "Diagnosis and management of thyrotoxicosis". BMJ. 349: g5128. PMID 25146390.
  11. "Think thyrotoxicosis factitia - measure thyroglobulin | The BMJ".

Template:WH Template:WS